Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123382 · ClinicalTrials.gov registry record · NA
Electrical Stimulation for Hemiplegic Shoulder Pain
A NA study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01123382 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT01123382, a NA study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Post-stroke shoulder pain is a major rehabilitation problem affecting moderate to severely impaired stroke survivors. Surface electrical stimulation (ES) of muscles surrounding the hemiparetic shoulder has been demonstrated to be beneficial, but despite the evidence for therapeutic benefit, the clinical implementation of surface ES for poststroke shoulder pain has been difficult. In order to address the limitations of surface ES, the investigative team pioneered the development of percutaneous intramuscular (IM) ES for the treatment of post-stroke shoulder pain. However, prior to acceptance by the clinical community, additional gaps in the scientific and clinical knowledge need to be addressed. This study begins to do so. The primary objective is to estimate the relative pain reduction associated with IM ES vs. "usual care." We hypothesize that the IM ES group will exhibit a larger effect size with respect to pain reduction compared to "usual care". A secondary objective is to estimate the effect on health related QOL of IM ES vs. "usual care." Demonstration of improvement in QOL will validate the clinical relevance of the intervention. We hypothesize that the IM ES group will exhibit greater improvement in health related QOL compared to "usual care".
Interventions
- DEVICE Intramuscular Electrical Stimulator
- OTHER Outpatient Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123382
The ClinicalTrials.gov registry entry for NCT01123382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intramuscular Electrical Stimulator is the first listed.
NCT01123382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123382 about?
NCT01123382 is a clinical study titled "Electrical Stimulation for Hemiplegic Shoulder Pain". Post-stroke shoulder pain is a major rehabilitation problem affecting moderate to severely impaired stroke survivors. Surface electrical stimulation (ES) of muscles surrounding the hemiparetic shoulder has been demonstrated to be beneficial, but despite the evidence for therapeutic benefit, the clin...
What is the current status of trial NCT01123382?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2010-01. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01123382?
The interventions under investigation include: Intramuscular Electrical Stimulator (DEVICE), Outpatient Therapy (OTHER).
Who is sponsoring clinical trial NCT01123382?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.